Decreased 11β-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice
Chronic nicotine exposure significantly increases hypertensive risk in smokers, but the underlying mechanisms are poorly understood. In the kidneys, 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) catalyzes the conversion from active into inactive glucocorticoids and plays a pivotal role in the r...
Gespeichert in:
Veröffentlicht in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 2021-04 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | |
creator | Wang, Ying Wang, Jian Yang, Rong Wang, Piwen Porche, Rene Kim, Samuel Lutfy, Kabirullah Liu, Limei Friedman, Theodore C. Jiang, Meisheng Liu, Yanjun |
description | Chronic nicotine exposure significantly increases hypertensive risk in smokers, but the underlying mechanisms are poorly understood. In the kidneys, 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) catalyzes the conversion from active into inactive glucocorticoids and plays a pivotal role in the regulation of blood pressure. We hypothesized that nicotine-induced blood pressure elevation is in part mediated by change in renal 11β-HSD2 leading to higher MR (mineralocorticoid receptor) occupancy. Here, we show that nicotine exposure markedly decreased the expression and activity of renal 11β-HSD2 and increased the mean systolic arterial pressure in C57BL/6J mice. Reduction of renal 11β-HSD2 expression by nicotine was correlated with the suppression of C/EBPβ (CCAAT/enhancer-binding protein-β) and activation of Akt protein kinase phosphorylation (pThr308Akt/PKB) within the kidney. Conversely, nicotine-treated mice had elevated renal MR and epithelial sodium channel-α abundance. Treatment with the MR antagonist spironolactone significantly decreased the elevated mean systolic blood pressure and corrected ENaC along with inhibition of pThr308Akt/PKB within the kidney in nicotine-treated mice. Suppression of Akt/PKB activation by spironolactone was accompanied by upregulation of renal C/EBPβ and amelioration of nicotine-mediated reduction of 11β-HSD2. Addition of nicotine to mouse renal cortical collecting duct M1 cells downregulated 11β-HSD2 and stimulated MR expression, and these effects are likely mediated by activation of Akt coupled inhibition of C/EBPβ. These findings suggest that nicotine-mediated suppression of 11β-HSD2 in the kidney may contribute to the development of nicotine/smoking-induced hypertension through decreasing the intrarenal deactivation of glucocorticoids. Spironolactone may prove useful in protecting against the hypertensive risks of nicotine/smoking. |
doi_str_mv | 10.1161/HYPERTENSIONAHA.120.16458 |
format | Article |
fullrecord | <record><control><sourceid>wolterskluwer</sourceid><recordid>TN_cdi_wolterskluwer_health_00004268-900000000-93741</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>00004268-900000000-93741</sourcerecordid><originalsourceid>FETCH-wolterskluwer_health_00004268-900000000-937413</originalsourceid><addsrcrecordid>eNqdjk1OwzAQhb0AifJzh-EAbu3UpM2ytEGpUENFs4BVFeKhMTV2ZTu0OQn34CCciVTqCXibkebN-94QcstZn_OYD7LXZfpcpPlq_pRPskmfR50Ri7vxGekxngiacP5yQS69_2CMCyFGPfI9w8ph6VEC578_NGuls4fWB3RWSZhhfVxs0HQnULQ7hAjSw86h98oaUAZCjfCopMEWFmULU2uCU29NQAgWclXZoAwOVp92q8yGzo1sqq7sXlsrYXnkNA4h1fhVhhNxoSq8JufvpfZ4c5pXRDykxTSje6u73_xWN3t06xpLHeo16ySieEwTdhJNhiPBh_-M_QGeMmjR</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Decreased 11β-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice</title><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Wang, Ying ; Wang, Jian ; Yang, Rong ; Wang, Piwen ; Porche, Rene ; Kim, Samuel ; Lutfy, Kabirullah ; Liu, Limei ; Friedman, Theodore C. ; Jiang, Meisheng ; Liu, Yanjun</creator><creatorcontrib>Wang, Ying ; Wang, Jian ; Yang, Rong ; Wang, Piwen ; Porche, Rene ; Kim, Samuel ; Lutfy, Kabirullah ; Liu, Limei ; Friedman, Theodore C. ; Jiang, Meisheng ; Liu, Yanjun</creatorcontrib><description>Chronic nicotine exposure significantly increases hypertensive risk in smokers, but the underlying mechanisms are poorly understood. In the kidneys, 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) catalyzes the conversion from active into inactive glucocorticoids and plays a pivotal role in the regulation of blood pressure. We hypothesized that nicotine-induced blood pressure elevation is in part mediated by change in renal 11β-HSD2 leading to higher MR (mineralocorticoid receptor) occupancy. Here, we show that nicotine exposure markedly decreased the expression and activity of renal 11β-HSD2 and increased the mean systolic arterial pressure in C57BL/6J mice. Reduction of renal 11β-HSD2 expression by nicotine was correlated with the suppression of C/EBPβ (CCAAT/enhancer-binding protein-β) and activation of Akt protein kinase phosphorylation (pThr308Akt/PKB) within the kidney. Conversely, nicotine-treated mice had elevated renal MR and epithelial sodium channel-α abundance. Treatment with the MR antagonist spironolactone significantly decreased the elevated mean systolic blood pressure and corrected ENaC along with inhibition of pThr308Akt/PKB within the kidney in nicotine-treated mice. Suppression of Akt/PKB activation by spironolactone was accompanied by upregulation of renal C/EBPβ and amelioration of nicotine-mediated reduction of 11β-HSD2. Addition of nicotine to mouse renal cortical collecting duct M1 cells downregulated 11β-HSD2 and stimulated MR expression, and these effects are likely mediated by activation of Akt coupled inhibition of C/EBPβ. These findings suggest that nicotine-mediated suppression of 11β-HSD2 in the kidney may contribute to the development of nicotine/smoking-induced hypertension through decreasing the intrarenal deactivation of glucocorticoids. Spironolactone may prove useful in protecting against the hypertensive risks of nicotine/smoking.</description><identifier>ISSN: 0194-911X</identifier><identifier>DOI: 10.1161/HYPERTENSIONAHA.120.16458</identifier><language>eng</language><publisher>American Heart Association, Inc</publisher><ispartof>Hypertension (Dallas, Tex. 1979), 2021-04</ispartof><rights>American Heart Association, Inc</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Wang, Ying</creatorcontrib><creatorcontrib>Wang, Jian</creatorcontrib><creatorcontrib>Yang, Rong</creatorcontrib><creatorcontrib>Wang, Piwen</creatorcontrib><creatorcontrib>Porche, Rene</creatorcontrib><creatorcontrib>Kim, Samuel</creatorcontrib><creatorcontrib>Lutfy, Kabirullah</creatorcontrib><creatorcontrib>Liu, Limei</creatorcontrib><creatorcontrib>Friedman, Theodore C.</creatorcontrib><creatorcontrib>Jiang, Meisheng</creatorcontrib><creatorcontrib>Liu, Yanjun</creatorcontrib><title>Decreased 11β-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice</title><title>Hypertension (Dallas, Tex. 1979)</title><description>Chronic nicotine exposure significantly increases hypertensive risk in smokers, but the underlying mechanisms are poorly understood. In the kidneys, 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) catalyzes the conversion from active into inactive glucocorticoids and plays a pivotal role in the regulation of blood pressure. We hypothesized that nicotine-induced blood pressure elevation is in part mediated by change in renal 11β-HSD2 leading to higher MR (mineralocorticoid receptor) occupancy. Here, we show that nicotine exposure markedly decreased the expression and activity of renal 11β-HSD2 and increased the mean systolic arterial pressure in C57BL/6J mice. Reduction of renal 11β-HSD2 expression by nicotine was correlated with the suppression of C/EBPβ (CCAAT/enhancer-binding protein-β) and activation of Akt protein kinase phosphorylation (pThr308Akt/PKB) within the kidney. Conversely, nicotine-treated mice had elevated renal MR and epithelial sodium channel-α abundance. Treatment with the MR antagonist spironolactone significantly decreased the elevated mean systolic blood pressure and corrected ENaC along with inhibition of pThr308Akt/PKB within the kidney in nicotine-treated mice. Suppression of Akt/PKB activation by spironolactone was accompanied by upregulation of renal C/EBPβ and amelioration of nicotine-mediated reduction of 11β-HSD2. Addition of nicotine to mouse renal cortical collecting duct M1 cells downregulated 11β-HSD2 and stimulated MR expression, and these effects are likely mediated by activation of Akt coupled inhibition of C/EBPβ. These findings suggest that nicotine-mediated suppression of 11β-HSD2 in the kidney may contribute to the development of nicotine/smoking-induced hypertension through decreasing the intrarenal deactivation of glucocorticoids. Spironolactone may prove useful in protecting against the hypertensive risks of nicotine/smoking.</description><issn>0194-911X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqdjk1OwzAQhb0AifJzh-EAbu3UpM2ytEGpUENFs4BVFeKhMTV2ZTu0OQn34CCciVTqCXibkebN-94QcstZn_OYD7LXZfpcpPlq_pRPskmfR50Ri7vxGekxngiacP5yQS69_2CMCyFGPfI9w8ph6VEC578_NGuls4fWB3RWSZhhfVxs0HQnULQ7hAjSw86h98oaUAZCjfCopMEWFmULU2uCU29NQAgWclXZoAwOVp92q8yGzo1sqq7sXlsrYXnkNA4h1fhVhhNxoSq8JufvpfZ4c5pXRDykxTSje6u73_xWN3t06xpLHeo16ySieEwTdhJNhiPBh_-M_QGeMmjR</recordid><startdate>20210405</startdate><enddate>20210405</enddate><creator>Wang, Ying</creator><creator>Wang, Jian</creator><creator>Yang, Rong</creator><creator>Wang, Piwen</creator><creator>Porche, Rene</creator><creator>Kim, Samuel</creator><creator>Lutfy, Kabirullah</creator><creator>Liu, Limei</creator><creator>Friedman, Theodore C.</creator><creator>Jiang, Meisheng</creator><creator>Liu, Yanjun</creator><general>American Heart Association, Inc</general><scope/></search><sort><creationdate>20210405</creationdate><title>Decreased 11β-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice</title><author>Wang, Ying ; Wang, Jian ; Yang, Rong ; Wang, Piwen ; Porche, Rene ; Kim, Samuel ; Lutfy, Kabirullah ; Liu, Limei ; Friedman, Theodore C. ; Jiang, Meisheng ; Liu, Yanjun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-wolterskluwer_health_00004268-900000000-937413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Ying</creatorcontrib><creatorcontrib>Wang, Jian</creatorcontrib><creatorcontrib>Yang, Rong</creatorcontrib><creatorcontrib>Wang, Piwen</creatorcontrib><creatorcontrib>Porche, Rene</creatorcontrib><creatorcontrib>Kim, Samuel</creatorcontrib><creatorcontrib>Lutfy, Kabirullah</creatorcontrib><creatorcontrib>Liu, Limei</creatorcontrib><creatorcontrib>Friedman, Theodore C.</creatorcontrib><creatorcontrib>Jiang, Meisheng</creatorcontrib><creatorcontrib>Liu, Yanjun</creatorcontrib><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Ying</au><au>Wang, Jian</au><au>Yang, Rong</au><au>Wang, Piwen</au><au>Porche, Rene</au><au>Kim, Samuel</au><au>Lutfy, Kabirullah</au><au>Liu, Limei</au><au>Friedman, Theodore C.</au><au>Jiang, Meisheng</au><au>Liu, Yanjun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased 11β-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><date>2021-04-05</date><risdate>2021</risdate><issn>0194-911X</issn><abstract>Chronic nicotine exposure significantly increases hypertensive risk in smokers, but the underlying mechanisms are poorly understood. In the kidneys, 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) catalyzes the conversion from active into inactive glucocorticoids and plays a pivotal role in the regulation of blood pressure. We hypothesized that nicotine-induced blood pressure elevation is in part mediated by change in renal 11β-HSD2 leading to higher MR (mineralocorticoid receptor) occupancy. Here, we show that nicotine exposure markedly decreased the expression and activity of renal 11β-HSD2 and increased the mean systolic arterial pressure in C57BL/6J mice. Reduction of renal 11β-HSD2 expression by nicotine was correlated with the suppression of C/EBPβ (CCAAT/enhancer-binding protein-β) and activation of Akt protein kinase phosphorylation (pThr308Akt/PKB) within the kidney. Conversely, nicotine-treated mice had elevated renal MR and epithelial sodium channel-α abundance. Treatment with the MR antagonist spironolactone significantly decreased the elevated mean systolic blood pressure and corrected ENaC along with inhibition of pThr308Akt/PKB within the kidney in nicotine-treated mice. Suppression of Akt/PKB activation by spironolactone was accompanied by upregulation of renal C/EBPβ and amelioration of nicotine-mediated reduction of 11β-HSD2. Addition of nicotine to mouse renal cortical collecting duct M1 cells downregulated 11β-HSD2 and stimulated MR expression, and these effects are likely mediated by activation of Akt coupled inhibition of C/EBPβ. These findings suggest that nicotine-mediated suppression of 11β-HSD2 in the kidney may contribute to the development of nicotine/smoking-induced hypertension through decreasing the intrarenal deactivation of glucocorticoids. Spironolactone may prove useful in protecting against the hypertensive risks of nicotine/smoking.</abstract><pub>American Heart Association, Inc</pub><doi>10.1161/HYPERTENSIONAHA.120.16458</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 2021-04 |
issn | 0194-911X |
language | eng |
recordid | cdi_wolterskluwer_health_00004268-900000000-93741 |
source | American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
title | Decreased 11β-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T09%3A48%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wolterskluwer&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%2011%CE%B2-Hydroxysteroid%20Dehydrogenase%20Type%202%20Expression%20in%20the%20Kidney%20May%20Contribute%20to%20Nicotine/Smoking-Induced%20Blood%20Pressure%20Elevation%20in%20Mice&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Wang,%20Ying&rft.date=2021-04-05&rft.issn=0194-911X&rft_id=info:doi/10.1161/HYPERTENSIONAHA.120.16458&rft_dat=%3Cwolterskluwer%3E00004268-900000000-93741%3C/wolterskluwer%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |